Form 4: Clover Health Investments CEO, Conrad Wai, Acquires 726,114 Shares of Class A Common Stock

Conrad Wai, CEO of Counterpart Health (and officer of Clover Health Investments), acquired 726,114 shares of Class A Common Stock on October 15, 2024, bringing his total holdings to 3,578,246 shares.

Summary

• On October 15, 2024, Conrad Wai, CEO of Counterpart Health and an officer of Clover Health Investments, acquired 726,114 shares of Class A Common Stock.
• The acquisition was related to a time-based restricted stock unit award (RSUs).
• Following the transaction, Wai directly owns 3,578,246 shares of Class A Common Stock.
• The RSUs vest over time, with 25% vesting on the first anniversary of October 15, 2024, and the remaining RSUs vesting in twelve equal quarterly installments until October 15, 2028, subject to continued service.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard disclosure of stock ownership changes. The acquisition of shares by an officer is generally viewed as a positive sign, but it's not overwhelmingly positive as it's part of a pre-arranged vesting schedule.

Positives

• The acquisition of shares by a key officer could be seen as a positive signal, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedule of the RSUs extends to October 15, 2028, suggesting a long-term commitment from the reporting person.

Industry Context

Insider transactions are closely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. This transaction is a routine disclosure of stock ownership changes by a company officer.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a key officer.

Key Dates